The Valley Desk

NCT01904409 · Interventional trial

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

Overall registry status Completed

Phase 2

Conditions Liver Cirrhosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov